drugset / Trial / NCT01840371

Randomized Controlled Study for Analyzing Clinical Benefit of Pain Focused Sedation With Combination of Fentanyl and Propofol During Endoscopic Retrograde Cholangiopancreatography (ERCP)

NCT01840371

Completed 220 enrolled Yonsei University
RandomizedParallel-groupSingle-blind

Summary

The investigators study is the randomized controlled study for analyzing clinical benefit of pain focused sedation with combination of fentanyl and propofol during Endoscopic retrograde cholangiopancreatography (ERCP). The investigators will assess recovery time and adverse effect during ERCP as the primary end point between two group. The investigators will also access satisfaction score for endoscopist and patients as the secondary end point.

Timeline

Start
2013-04
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 1 ug/kg Intravenous
Subject Meperidine Unknown 25 mg Intravenous
Subject Propofol Small molecule 30 ug/kg Intravenous
Subject Propofol Small molecule 60 ug/kg Intravenous

Indications

No indication recorded.